Draganfly Inc (DPRO)vsZepp Health Corp (ZEPP)
DPRO
Draganfly Inc
$5.38
+6.11%
TECHNOLOGY · Cap: $214.23M
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Zepp Health Corp generates 3249% more annual revenue ($258.90M vs $7.73M). ZEPP leads profitability with a -15.5% profit margin vs -297.3%. ZEPP earns a higher WallStSmart Score of 41/100 (D).
DPRO
Avoid21
out of 100
Grade: F
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for DPRO.
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
18.5% revenue growth
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -45.4% — below average capital efficiency
Negative free cash flow — burning cash
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : DPRO
The strongest argument for DPRO centers on Price/Book, Revenue Growth. Revenue growth of 18.5% demonstrates continued momentum.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : DPRO
The primary concerns for DPRO are EPS Growth, Market Cap, Return on Equity.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
DPRO profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.
DPRO carries more volatility with a beta of 3.57 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor COMPUTER HARDWARE industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ZEPP scores higher overall (41/100 vs 21/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Draganfly Inc
TECHNOLOGY · COMPUTER HARDWARE · USA
Draganfly Inc. (DPRO) is a pioneering force in the drone technology sector, focusing on the design and manufacture of advanced unmanned aerial vehicles (UAVs) and innovative software solutions tailored for both commercial and governmental uses. With significant penetration in key industries such as agriculture, public safety, and logistics, the company utilizes its cutting-edge technologies to enhance operational efficiency and data collection. Draganfly's unwavering commitment to research and development fosters continuous improvements in flight performance and artificial intelligence, reinforcing its position as a significant player in the dynamic UAV market. Supported by strategic partnerships and a diverse clientele, Draganfly is well-positioned for sustained growth and leadership within the drone industry.
Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other COMPUTER HARDWARE Stocks
Want to dig deeper into these stocks?